EP Patent

EP1993540A2 — Compositions and methods for the treatment of immunoinflammatory disorders

Assigned to Zalicus Inc · Expires 2008-11-26 · 17y expired

What this patent protects

The invention features methods and kits for treating an immunoinflammatory disorder, by administering to a patient diagnosed with or at risk of developing such immunoinflammatory disorder an adenosine activity upregulator in combination with one or more additional agents.

USPTO Abstract

The invention features methods and kits for treating an immunoinflammatory disorder, by administering to a patient diagnosed with or at risk of developing such immunoinflammatory disorder an adenosine activity upregulator in combination with one or more additional agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP1993540A2
Jurisdiction
EP
Classification
—
Expires
2008-11-26
Drug substance claim
No
Drug product claim
No
Assignee
Zalicus Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.